[et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_color=”#f15e35″ background_image=”https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-content\/uploads\/2025\/03\/coeur.png” background_size=”initial” background_position=”center_right” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”|800|||||||” text_font_size=”28px” header_line_height=”1.5em” global_colors_info=”{}”]<\/p>\n
DAY 2 [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”3px|||||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n 08:30 Welcome coffee in the exhibition hall<\/span><\/strong><\/p>\n \u00a008:45 Unraveling the complexity of multivalvular heart diseases: challenges & solutions<\/span><\/strong> 08:45 Case-based presentation. David Vancraeynest<\/span> \u00a009:40 Game-changers in valvular heart disease<\/span><\/strong> 09:40 Phenotyping & staging valvular heart disease. Mani Vannan<\/span><\/p>\n 10:05 Coffee break in the exhibition hall: poster display of accepted abstracts<\/span><\/strong><\/p>\n \u00a010:35 Jekyll & Hyde session: the best approach for asymptomatic aortic stenosis<\/span><\/strong> 10:35 Conservative management: a prudent approach? Philippe Pibarot<\/span> \u00a011:15 Prism vision: the best approach for \u201cat risk\u201d moderate aortic stenosis<\/span><\/strong> 11:15 Conservative management: a prudent approach? Augustin Coisne<\/span> \u00a012:0 The forgotten valvular heart disease: rheumatic VHD<\/span><\/strong> 12:0 The global burden of rheumatic valve disease. Geu-Ru Hong<\/span> 13:00 Lunch break in the exhibition hall: Poster Display of accepted abstracts<\/span><\/strong><\/p>\n \u00a014:00 Cutting-edge insights in tricuspid regurgitation<\/span><\/strong> 14:00 Risk scoring in tricuspid regurgitation: a game changer? Erwan Donal<\/span> \u00a015:00 Valvular heart disease in high-risk situations<\/span><\/strong> 15:00 Pregnancy & VHD: maternal & fetal risks. Agnes Pasquet<\/span> 16:10 Closing remarks: Patrizio Lancellotti<\/span><\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#f15f35″ global_colors_info=”{}”][et_pb_fullwidth_image src=”https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-content\/uploads\/2023\/03\/footer.png” title_text=”footer” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#f15f35″ width=”80%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_fullwidth_image][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" DAY 2 FRIDAY 2608:30 Welcome coffee in the exhibition hall \u00a008:45 Unraveling the complexity of multivalvular heart diseases: challenges & solutionsChairs: Philippe Unger, Mani Vannan 08:45 Case-based presentation. David Vancraeynest08:55 Understanding the hemodynamic interplay. Alison Duncan09:05 Risk stratification & decision-making. Nina Ajmone09:15 Surgical vs. transcatheter approaches. Joelle Kefer09:25 Round table discussion with expert\u2019s panel: Rodolfo […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-6619","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/pages\/6619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/comments?post=6619"}],"version-history":[{"count":0,"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/pages\/6619\/revisions"}],"wp:attachment":[{"href":"https:\/\/divine-id.site\/EUROVALVE\/2025\/wp-json\/wp\/v2\/media?parent=6619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nFRIDAY 26<\/span><\/p>\n
Chairs: Philippe Unger, Mani Vannan<\/span><\/strong><\/p>\n
08:55 Understanding the hemodynamic interplay. Alison Duncan<\/span>
09:05 Risk stratification & decision-making. Nina Ajmone<\/span>
09:15 Surgical vs. transcatheter approaches. Joelle Kefer<\/span>
09:25 Round table discussion with expert\u2019s panel: Rodolfo Citro, Krzysztof Smar\u017c, Tadafumi Sugimoto<\/span><\/p>\n
Chairs: Erwan Donal, Gilbert Habib<\/span><\/strong><\/p>\n
Chairs: Kalil Fattouch, Konstantinos Papadopoulos, Alessandro Parolari<\/span><\/strong><\/p>\n
11:55 Early intervention: acting before it\u2019s too late. Philippe Pibarot<\/span>
11:05 Expert discussion and closing remarks: Geu-Ru Hong, Mathieu Lempereur<\/span><\/p>\n
Chairs: Gilbert Habib, Patrizio Lancellotti, Giovanni La Canna<\/span><\/strong><\/p>\n
11:30 Early intervention: acting before it\u2019s too late. Corrado Tamburino<\/span>
11:45 Expert discussion and closing remarks: Samuel Bruls, Ciro Santoro, Laurent Davin, Philippe Pibarot<\/span><\/p>\n
Chairs: Geu-Ru Hong, Jadranka Separovic<\/span><\/strong><\/p>\n
12.15 Physiopathology of rheumatic heart disease. Romain Capoulade<\/span>
12.30 Medical treatment and anticoagulation in rheumatic mitral stenosis. Claire Bouleti<\/span>
12.45 The place of percutaneous treatment in rheumatic disease. Alison Duncan<\/span><\/p>\n
Chairs: Bernard Cosyns, Gilles Dreyfus, Vincent Tchana-Sato<\/span><\/strong><\/p>\n
14:10 The right ventricle: does it really matter? Charlotte Lee Frost<\/span>
14:20 Isolated TR: when and how should we intervene? Matteo Pettinari<\/span>
14:30 Key lessons from randomized trials. Tadafumi Sugimoto<\/span>
14:40 Round table discussion with expert\u2019s panel: Eustachio Agricola, Giuseppina Novo, Adriana Postolache<\/p>\n
Chairs: Erwan Donal, Carla Sousa, Simona Sperlongano<\/span><\/strong><\/p>\n
15:10 VHD in non-cardiac surgery: perioperative strategies. Simona Sperlongano<\/span>
15:20 Active neoplasia & VHD: balancing cancer & cardiac care. Giuseppina Novo<\/span>
15:30 Athletes with VHD: sports eligibility & restrictions. Lieven Herbots<\/span>
15:40 Expert panel discussion: Raluca Dulgheru, Marie Moonen<\/span><\/p>\n